The levels of soluble B7-H4 in blood correlate with tumor stage, poor prognosis, and pathological types, indicating that B7-H4 may be a potential diagnostic marker and a prognostic predictor for ovarian cancer. This evidence concerns the gene VTCN1 and ovarian carcinoma.